Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation-a retrospective analysis on seven patients.


Journal

Annals of hematology
ISSN: 1432-0584
Titre abrégé: Ann Hematol
Pays: Germany
ID NLM: 9107334

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 29 11 2018
accepted: 06 04 2019
pubmed: 18 4 2019
medline: 26 7 2019
entrez: 18 4 2019
Statut: ppublish

Résumé

Refractory skin ulcers due to severe chronic graft-versus-host disease (cGVHD) remain to be associated with significant morbidity and mortality.We performed an allogeneic donor skin transplantation in seven adult patients after allogeneic hematopoietic stem cell transplantation for cGVHD-associated refractory skin ulcers. While four patients received a split skin graft (SSG), in one patient, a full thickness skin graft for two small refractory ulcers of the ankle was performed, and one patient received in vitro expanded donor keratinocyte grafts derived from hair roots of the original unrelated donor. In one additional patient, a large deep fascial defect of the lower leg was covered with an autologous greater omentum free graft before coverage with an allogeneic SSG. An additional patient was treated with an autologous scrotal skin graft for a refractory ulcer associated with deep sclerosis of cGVHD after unrelated donor transplantation.All skin grafts engrafted and resulted in permanent coverage of the grafted ulcers without any signs of immunological mediated damage. In the patient receiving in vitro expanded keratinocyte grafts, two localized ulcers were permanently covered by donor skin while this approach failed to cover extensive circular ulcers of the lower legs.Allogeneic donor skin grafts are a valuable treatment option in refractory ulcers due to cGVHD but are restricted mainly to related donors while keratinocyte grafts from unrelated donors remain experimental. In male patients lacking a related donor, autologous scrotal skin graft may be an alternative option.

Identifiants

pubmed: 30993415
doi: 10.1007/s00277-019-03687-x
pii: 10.1007/s00277-019-03687-x
doi:

Substances chimiques

Immunosuppressive Agents 0
Cyclophosphamide 8N3DW7272P

Types de publication

Case Reports Journal Article Multicenter Study

Langues

eng

Pagination

1867-1875

Auteurs

P Lamby (P)

Department of Plastic, Reconstructive and Hand Surgery, University Hospital, Regensburg, Germany.

D Wolff (D)

Department of Internal Medicine III, University of Regensburg, F.J. Strauss Allee 11, 93053, Regensburg, Germany. daniel.wolff@ukr.de.

S Mielke (S)

Allogeneic Stem Cell Transplantation Section, Department of Internal Medicine II, Würzburg University Medical Center, Würzburg, Germany.
Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital and Karolinska Institutet, SE-171 77, Stockholm, Sweden.

G U Grigoleit (GU)

Allogeneic Stem Cell Transplantation Section, Department of Internal Medicine II, Würzburg University Medical Center, Würzburg, Germany.

P Ljungman (P)

Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital and Karolinska Institutet, SE-171 77, Stockholm, Sweden.

I Hilgendorf (I)

Universitätsklinikum Jena, Klinik für Innere Medizin II, Abteilung für Hämatologie und Internistische Onkologie, Jena, Deutschland, Germany.

E Holler (E)

Department of Internal Medicine III, University of Regensburg, F.J. Strauss Allee 11, 93053, Regensburg, Germany.

B Holler (B)

Department of Internal Medicine III, University of Regensburg, F.J. Strauss Allee 11, 93053, Regensburg, Germany.

D Weber (D)

Department of Internal Medicine III, University of Regensburg, F.J. Strauss Allee 11, 93053, Regensburg, Germany.

W Herr (W)

Department of Internal Medicine III, University of Regensburg, F.J. Strauss Allee 11, 93053, Regensburg, Germany.

D Schiltz (D)

Department of Plastic, Reconstructive and Hand Surgery, University Hospital, Regensburg, Germany.

S Klein (S)

Department of Plastic, Reconstructive and Hand Surgery, University Hospital, Regensburg, Germany.

S Graf (S)

Department of Plastic, Reconstructive and Hand Surgery, University Hospital, Regensburg, Germany.

V Bjornhagen-Safwenberg (V)

Department of Plastic Surgery, Karolinska University Hospital, Stockholm, Sweden.

J Dolderer (J)

Department of Plastic, Reconstructive and Hand Surgery, University Hospital, Regensburg, Germany.

L Prantl (L)

Department of Plastic, Reconstructive and Hand Surgery, University Hospital, Regensburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH